product name Labetalol HCl
Description: Labetalol HCl is a competitive, dual antagonist for both selective alpha1-adrenergic and nonselective beta-adrenergic receptors with antihypertensive properties. Labetalol is used to treat high blood pressure. It can be given intravenously in severe hypertensive situations, or by mouth for long term hypertension management.
References: Expert Opin Drug Saf. 2015 Mar;14(3):453-61.
603.75
Formula
C36H45NO7
CAS No.
94749-08-3
Storage
-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)
DMSO: 100 mg/mL (165.6 mM)
Water: <1 mg/mL
Ethanol: 4 mg/mL (6.6 mM)
Solubility (In vivo)
Synonyms
other peoduct :References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/19397743
| In Vitro |
In vitro activity: Kinase Assay: Cell Assay: |
|---|---|
| In Vivo | |
| Animal model | |
| Formulation & Dosage | |
| References |
3-Deazaneplanocin A (hydrochloride)
Related Posts
product name Labetalol HCl
Description: Labetalol HCl is a competitive, dual antagonist for both selective alpha1-adrenergic and nonselective beta-adrenergic receptors with antihypertensive properties. Labetalol is used to treat high blood pressure. It can be given intravenously in severe hypertensive situations, or by mouth for long term hypertension management.
References: Expert Opin Drug Saf. 2015 Mar;14(3):453-61.
603.75
Formula
C36H45NO7
CAS No.
94749-08-3
Storage
-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)
DMSO: 100 mg/mL (165.6 mM)
Water: <1 mg/mL
Ethanol: 4 mg/mL (6.6 mM)
Solubility (In vivo)
Synonyms
other peoduct :References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/19397743
| In Vitro |
In vitro activity: Kinase Assay: Cell Assay: |
|---|---|
| In Vivo | |
| Animal model | |
| Formulation & Dosage | |
| References |
3-Deazaneplanocin A (hydrochloride)